Pharmacokinetics of Posaconazole in Allogeneic Transplant Patients With Mucositis

Trial Profile

Pharmacokinetics of Posaconazole in Allogeneic Transplant Patients With Mucositis

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Posaconazole (Primary)
  • Indications Aspergillosis; Candidiasis; Mycoses
  • Focus Pharmacokinetics
  • Most Recent Events

    • 18 Apr 2016 New trial record
    • 11 Apr 2016 Results published in the European Journal of Clinical Pharmacology
    • 11 Apr 2016 Status changed from recruiting to completed, according to results published in the European Journal of Clinical Pharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top